Chi-Med’s Sinopharm Deal Opens Doors To China Market For Partners, CEO Says
This article was originally published in PharmAsia News
Executive Summary
The joint venture allows the newly formed subsidiary Hutchison Sinopharm to sell pharmaceuticals all over China and become a “super partner” for multinationals selling medicines in the country.